M1 Macrophage-Derived Sonoresponsive Nanoparticles for Sonodynamic Anticancer Therapy

BACKGROUND: Many nanocarriers currently developed have potential in tumor targeting, but there are still several limitations to their applications in clinical treatment. It is crucial to explore novel nanocarriers with higher biocompatibility and targeting efficiency to overcome the barriers of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Sijie, Wang, Jiahao, Liao, Haiqin, Tang, Kui, Xu, Yan, Wang, Long, Niu, Chengcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555221/
https://www.ncbi.nlm.nih.gov/pubmed/36246937
http://dx.doi.org/10.2147/IJN.S381170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555221/
https://www.ncbi.nlm.nih.gov/pubmed/36246937
http://dx.doi.org/10.2147/IJN.S381170

Ejemplares similares